IRS2

ConceptMentioned in 1 video

A key intermediate in the insulin signaling pathway specific to the liver, undergoing tyrosine phosphorylation to activate PI3-kinase.

Videos Mentioning IRS2

#140 - Gerald Shulman, MD, PhD: Insulin resistance—molecular mechanisms and clinical implications

#140 - Gerald Shulman, MD, PhD: Insulin resistance—molecular mechanisms and clinical implications

Peter Attia MD

A key intermediate in the insulin signaling pathway specific to the liver, undergoing tyrosine phosphorylation to activate PI3-kinase.